Donald Trump’s press conference revealed his strategic ambiguity regarding abortion policy. He seemed open to limiting access to mifepristone but lacked clarity about his stance.
Trump appears to be inclined to outsource abortion policy to anti-abortion advocates, following a pattern from his first term, endangering reproductive rights significantly.
Throughout the campaign, Trump has avoided direct answers about significant abortion-related issues, signaling a desire to maintain obfuscation and plausible deniability.
Despite previously seeming hesitant about mifepristone access, Trump now indicates potential openness toward federal action to restrict access to the drug.
Collection
[
|
...
]